AKT1 and Epstein-Barr virus infection: As expected, EBV infection led to an increase in AKT phosphorylation; conversely, elimination of EBV through the CRISPR/Cas9 system reduced AKT phosphorylation to levels similar to that of the EBV-negative control cells (Fig. 5a, b and Supplementary Fig. 5a).